Hackensack University Medical Center/John Theurer Cancer Center

Hackensack, New Jersey 07601

3 studies enrolling now · 21 studies all time

What they study most

Acute Leukemia of Ambiguous Lineage, Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Acute Myeloid Leukemia (AML), Acute Myeloid Leukemia With FMS-like Tyrosine Kinase (FLT3) Mutation, Adult T Cell Leukemia/Lymphoma, Advanced Breast Cancer, Advanced Malignant Neoplasm, Advanced Non-squamous Non-small-cell Lung Cancer, Advanced Solid Tumors, Bladder Cancer, Breast Cancer

Studies at this site

• Study Evaluating the Safety and Efficacy of HWK-007, a PTK7-directed Antibody Drug Conjugate in Participants With Advanced Solid Tumors — Recruiting now
• Selinexor and Backbone Treatments of Multiple Myeloma Patients — Recruiting now
• Study of ONO-4685 in Patients With Relapsed or Refractory T Cell Lymphoma — Recruiting now
• Brentuximab Vedotin and Nivolumab for the Treatment of Patients With Relapsed/Refractory Classical Hodgkin Lymphoma — Recruiting now
• Valemetostat Tosylate (DS-3201b), an Enhancer of Zeste Homolog (EZH) 1/2 Dual Inhibitor, for Relapsed/Refractory Peripheral T-Cell Lymphoma (VALENTINE-PTCL01) — Running, not enrolling
• A Study of ASP2215 (Gilteritinib) by Itself, ASP2215 Combined With Azacitidine or Azacitidine by Itself to Treat Adult Patients Who Have Recently Been Diagnosed With Acute Myeloid Leukemia With a FLT3 Gene Mutation and Who Cannot Receive Standard Chemotherapy — Completed
• First in Human Study of Ziftomenib in Relapsed or Refractory Acute Myeloid Leukemia — Running, not enrolling
• A Pilot Study of the Therapeutic Potential of Stem Cell Educator Therapy in Type 1 Diabetes — Completed
• Pivotal, Randomized, Open-label Study of Optune® (Tumor Treating Fields) Concomitant With RT & TMZ for the Treatment of Newly Diagnosed GBM — Completed
• A Study of Axicabtagene Ciloleucel in Participants With Relapsed/Refractory Indolent Non-Hodgkin Lymphoma — Completed
• Safety, PK, PD, Clinical Activity of KT-333 in Adult Patients With Refractory Lymphoma, Large Granular Lymphocytic Leukemia, Solid Tumors — Completed
• Palbociclib in Real World Practice — Completed
• FT536 Monotherapy and in Combination With Monoclonal Antibodies in Advanced Solid Tumors — Stopped early
• FT516 in Combination With Monoclonal Antibodies in Advanced Solid Tumors — Stopped early
• A Study of Anti-Cancer Therapies Targeting the MAPK Pathway in Patients With Advanced NSCLC — Completed
• FT500 as Monotherapy and in Combination With Immune Checkpoint Inhibitors in Subjects With Advanced Solid Tumors — Completed
• Study to Explore the Safety, Tolerability and Efficacy of MK-3475 in Combination With INCB024360 in Participants With Selected Cancers — Completed
• A Study That Switched Patients From Imatinib to Nilotinib and Then Was Followed by Treatment Cessation — Completed
• Study of BEGEDINA® vs "Conventional Treatment" for Treating Steroid-Resistant Acute GvHD — Stopped early
• A Phase 3 Study of Ganetespib in Combination With Docetaxel Versus Docetaxel Alone in Patients With Advanced NSCLC — Stopped early
• PRO#0118: Decitabine Plus Mini Flu-Bu — Completed